These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10582488)

  • 1. [Molecular pathology of colorectal cancer].
    Bosman FT; Joris F
    Rev Med Suisse Romande; 1999 Oct; 119(10):775-82. PubMed ID: 10582488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular pathology of colorectal cancer.
    Bosman FT
    Cytogenet Cell Genet; 1999; 86(2):112-7. PubMed ID: 10545700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic inflammatory bowel disease and cancer.
    Pohl C; Hombach A; Kruis W
    Hepatogastroenterology; 2000; 47(31):57-70. PubMed ID: 10690586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High sensitivity scanning of colorectal tumors and matched plasma DNA for mutations in APC, TP53, K-RAS, and BRAF genes with a novel DHPLC fluorescence detection platform.
    Lilleberg SL; Durocher J; Sanders C; Walters K; Culver K
    Ann N Y Acad Sci; 2004 Jun; 1022():250-6. PubMed ID: 15251969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. K-ras mutation: early detection in molecular diagnosis and risk assessment of colorectal, pancreas, and lung cancers--a review.
    Minamoto T; Mai M; Ronai Z
    Cancer Detect Prev; 2000; 24(1):1-12. PubMed ID: 10757118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatic mutations of the APC, KRAS, and TP53 genes in nonpolypoid colorectal adenomas.
    van Wyk R; Slezak P; Hayes VM; Buys CH; Kotze MJ; de Jong G; Rubio C; Dolk A; Jaramillo E; Koizumi K; Grobbelaar JJ
    Genes Chromosomes Cancer; 2000 Feb; 27(2):202-8. PubMed ID: 10612810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. K-ras codon 12 and 13 mutations are correlated with differential patterns of tumor cell dissemination in colorectal cancer patients.
    Conzelmann M; Linnemann U; Berger MR
    Int J Oncol; 2004 Jun; 24(6):1537-44. PubMed ID: 15138598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of APC and k-ras mutations in the serum of patients with colorectal cancer.
    Lauschke H; Caspari R; Friedl W; Schwarz B; Mathiak M; Propping P; Hirner A
    Cancer Detect Prev; 2001; 25(1):55-61. PubMed ID: 11270422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The multidisciplinary management of gastrointestinal cancer. The use of molecular markers in the diagnosis and treatment of colorectal cancer.
    Tejpar S
    Best Pract Res Clin Gastroenterol; 2007; 21(6):1071-87. PubMed ID: 18070704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limitations in molecular detection of lymph node micrometastasis from colorectal cancer.
    Klebig F; Fischer C; Petri S; Gerull H; Wagener C; Tschentscher P
    Diagn Mol Pathol; 2007 Jun; 16(2):91-5. PubMed ID: 17525678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic pathways in colorectal cancer: interest for the pathologist].
    Piard F; Martin L; Chapusot C; Ponnelle T; Faivre J
    Ann Pathol; 2002 Sep; 22(4):277-88. PubMed ID: 12410150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
    Couturier D
    Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced likelihood of metastases in patients with microsatellite-unstable colorectal cancer.
    Malesci A; Laghi L; Bianchi P; Delconte G; Randolph A; Torri V; Carnaghi C; Doci R; Rosati R; Montorsi M; Roncalli M; Gennari L; Santoro A
    Clin Cancer Res; 2007 Jul; 13(13):3831-9. PubMed ID: 17606714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Molecular-pathological problems of genetic diagnosis for colorectal cancer].
    Tomita N; Monden T; Sekimoto M; Monden M
    Nihon Geka Gakkai Zasshi; 1997 Mar; 98(3):366-72. PubMed ID: 9101543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative pathological examination of colorectal cancer.
    Micev M; Cosic-Micev M; Todorovic V
    Acta Chir Iugosl; 2000; 47(4 Suppl 1):67-76. PubMed ID: 11432246
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of cycling gradient capillary electrophoresis to detection of APC, K-ras, and DCC point mutations in patients with sporadic colorectal tumors.
    Minarik M; Minarikova L; Hrabikova M; Minarikova P; Hrabal P; Zavoral M
    Electrophoresis; 2004 Apr; 25(7-8):1016-21. PubMed ID: 15095442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-ras mutation type and the survival benefit from adjuvant chemotherapy in Dukes' C colorectal cancer.
    Gnanasampanthan G; Elsaleh H; McCaul K; Iacopetta B
    J Pathol; 2001 Dec; 195(5):543-8. PubMed ID: 11745689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recent advance of prognostic factor in human colorectal cancer].
    Itoh F; Yamamoto H; Fukushima H; Matsuno K; Imai K
    Gan To Kagaku Ryoho; 1998 Nov; 25(13):2028-35. PubMed ID: 9838903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TP53 mutation in colorectal cancer.
    Iacopetta B
    Hum Mutat; 2003 Mar; 21(3):271-6. PubMed ID: 12619112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.